Shareholder calls for sale of MoneyHero amid leadership void
Get Alerts MNY Hot Sheet
Join SI Premium – FREE
Jonathan Honig, who holds approximately 9.0% of MoneyHero Limited's (NASDAQ: MNY) outstanding Class A Ordinary Shares, issued an open letter to the company's board of directors on Sept. 29, 2026, urging it to retain an independent financial advisor and initiate a strategic review to explore a sale of the company.
Honig, who describes himself as the largest unaffiliated shareholder, cited four areas of concern: leadership uncertainty, stalled revenue growth, share price decline, and a lack of insider share purchases.
MoneyHero has operated without a permanent chief executive officer since April 2, 2026, when Rohith Murthy's tenure ended and CFO Danny Leung was named interim CEO. Murthy subsequently resigned from the board effective May 26, 2026. Honig noted that nearly six months have passed without a permanent appointment.
On the financial side, annual revenue fell from $80.7 million in fiscal year 2023 to $73.4 million in fiscal year 2025, falling short of a $100 million revenue target that prior management had stated in April 2025. The company reported its first profitable quarter in Q4 2025, but posted a net loss for the full year.
MoneyHero's shares closed at $0.675 on Sept. 28, 2026, a decline of more than 88% from the price at which the stock opened when the company went public in October 2023. Honig stated he believes the company is worth at least $1.50 per share in a transaction.
Honig also noted that, based on a review of public SEC filings, no director or executive officer appears to have purchased shares on the open market.
In the letter, Honig requested that the board respond by the close of business on Oct. 5, 2026, regarding its willingness to engage in further discussions.
You May Also Be Interested In
- American Vanguard acquires four Syngenta crop-protection brands in US
- Metallus wins $995M defense steel contract, gets $125M initial order
- NewAmsterdam Pharma begins Phase 2b trial of obicetrapib in Alzheimer's
Create E-mail Alert Related Categories
Board Changes, Hedge FundsRelated Entities
Clarium Capital Management, Peter Thiel, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share